Nav: Home

Cholesterol leash: Key tethering protein found to transport cellular cholesterol

April 16, 2018

Osaka - Despite its less-than-stellar reputation in the news, cholesterol is an essential molecule for living things. It serves as the building block for hormones and helps give shape to the membranes that enclose cells and their internal parts (Fig.1). Consequently, many diseases arise from defects in the proper transport of cholesterol. Now, researchers at Osaka University have shed new light on one of the key pathways used to transport cholesterol inside of cells.

"Intracellular cholesterol transport occurs through two pathways, vesicular and non-vesicular," lead author Tomoaki Sobajima explains. "The vesicular pathway shuttles cholesterol using vesicles that 'pinch off' from, and fuse with, cell membranes. The non-vesicular pathway is just as important to cholesterol transport, but many of the proteins involved still need to be identified for us to understand how exactly the pathway works."

The researchers set out to demystify non-vesicular transport using a screening assay, which allowed them to find proteins that interact with known players in the pathway. From this screening, they identified RELCH. Although not previously connected to cholesterol transport, RELCH was found to interact with two critical proteins in the pathway: Rab11 and OSBP. These interactions laid the initial groundwork for the key discovery in the study.

"Non-vesicular transport is thought to happen when two membranes tether together, allowing cholesterol to jump from one membrane to the next," Sobajima adds. "We set up an artificial system that lets us measure how well cholesterol moves along tethered cell membranes. What we found was that Rab11-containing membranes (or beads) and OSBP-containing membranes (or beads) tether together very effectively when RELCH is added to the mix (Fig.2), and cholesterol can then move easily across the membranes (Fig.3)."

The findings, published in The Journal of Cell Biology, may serve as a jumping-off point for further studies in this newly-uncovered transfer system for cholesterol.

"Our study suggests that RELCH is a key linkage protein that allows cholesterol to be transferred across Rab11-containing recycling endosomes to OSBP-containing Golgi membranes," lead investigator Akihiro Harada concludes. "Identifying the Rab11-RELCH-OSBP complex is a major step forward in understanding how non-vesicular transport operates. We believe the findings will eventually help drive the discovery process for treatments of cholesterol-related metabolic disorders involving this unique transport pathway."
-end-
Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan's leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan's most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university's ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Website: http://resou.osaka-u.ac.jp/en/top

Osaka University

Related Cholesterol Articles:

Cholesterol's effects on cellular membranes
The findings have far-reaching implications in the general understanding of disease, the design of drug delivery methods, and many other biological applications that require specific assumptions about the role of cholesterol in cell membranes.
Autism-cholesterol link
Study identifies genetic link between cholesterol alterations and autism.
Microbes might manage your cholesterol
Researchers discover a link between human blood cholesterol levels and a gene in the microbiome that could one day help people manage their cholesterol through diet, probiotics, or entirely new types of treatment.
Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov.
Rethinking how cholesterol is integrated into cells
Cholesterol is best known in connection with cardiovascular disease, but cholesterol is also vital for many fundamental processes in the body.
Seed oils are best for LDL cholesterol
Using a statistical technique called network meta-analysis, researchers have combined the results of dozens of studies of dietary oils to identify those with the best effect on patients' LDL cholesterol and other blood lipids.
Cholesterol leash: Key tethering protein found to transport cellular cholesterol
Cholesterol is an essential component of living organisms, but the mechanisms that transport cholesterol inside the cell are poorly understood.
New way to treat cholesterol may be on the horizon
A breakthrough discovery by scientists at Houston Methodist Research Institute could change the way we treat cholesterol.
How low should LDL cholesterol go?
New analysis shows that in a high-risk population, achieving ultra-low LDL cholesterol levels, down to <10 mg/dL, safely results in additional lowering of risk of cardiovascular events.
Does boosting 'good' cholesterol really improve your health?
A new review addresses the mysteries behind 'good' HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients.
More Cholesterol News and Cholesterol Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.